Concerns about patient choice, market dominance and purchasing power have been raised over Honeysuckle Health and Nib Group's fresh bid to collectively negotiate with private hospitals and other health providers.
Honeysuckle Health, a subsidiary of Nib Group, has applied to the Australian Competition and Consumer Commission (ACCC) to "enable the continued operation of the HH Buying Group" for a decade.